Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;25(10):2599-2607.
doi: 10.1038/s41380-018-0214-2. Epub 2018 Aug 16.

Association of anxiety with subcortical amyloidosis in cognitively normal older adults

Affiliations

Association of anxiety with subcortical amyloidosis in cognitively normal older adults

Bernard J Hanseeuw et al. Mol Psychiatry. 2020 Oct.

Erratum in

Abstract

Late-life anxiety has been associated with increased progression from normal cognition to amnestic MCI, suggesting that anxiety may be a neuropsychiatric symptom of Alzheimer's disease (AD) pathological changes and a possible marker of anatomical progression in preclinical AD. This study examined whether cortical or subcortical amyloidosis, indicating earlier or later stages of preclinical AD, was associated with greater self-reported anxiety among 118 cognitively normal volunteers, aged 65-90 years, and whether this association was stronger in APOEε4 carriers. Participants underwent Pittsburgh Compound B Positron Emission Tomography (PiB-PET) to assess fibrillar amyloid-β burden in cortical and subcortical regions, and measurement of anxiety using the Hospital Anxiety and Depression Scale-anxiety subscale. Higher PiB-PET measures in the subcortex (striatum, amygdala, and thalamus), but not in the cortex, were associated with greater anxiety, adjusting for demographics, cognition, and depression. Findings were similar using a cortico-striatal staging system and continuous PET measurements. Anxiety was highest in APOEε4 carriers with subcortical amyloidosis. This work supports in vivo staging of amyloid-β deposition in both cortical and subcortical regions as a promising approach to the study of neuropsychiatric symptoms such as anxiety in cognitively normal older individuals. Elevated anxiety symptoms in combination with high-risk biological factors such as APOEε4 and subcortical amyloid-β may identify participants closest to MCI for secondary prevention trials.

PubMed Disclaimer

Conflict of interest statement

BJH has served as a paid consultant for GE Healthcare. VJ, JJ, and RAB have no disclosures. DMR has served as a paid consultant for Eli Lilly, Janssen, and Biogen, and sits on the Scientific Advisory Board for Neurotrack. KAJ has served as paid consultant for Biogen, Janssen, Piramal, Novartis, Genetech, Roche, Lundbeck, Eli Lilly, Genzyme, AZtherapies, Abbvie, and Merck. RAS has served as a paid consultant for Abbvie, Biogen, Bracket, Genentech, Lundbeck, Roche, and Sanofi. She has served as a co-investigator for Avid, Eli Lilly, and Janssen. She has spoken at symposia sponsored by Eli Lilly, Biogen, and Janssen. NJD has received salary support from Eisai and Eli Lilly. She has served as a paid consultant to Avanir Pharmaceuticals. Her spouse is employed by Alkermes. None of these relationships are related to the content of the manuscript.

Figures

Fig. 1
Fig. 1
Anxiety scores do not differ by Neocortical PiB+/− Group or APOEε4 carrier status. Anxiety scores adjusted for age, sex, education, and Mini-Mental State Examination and Geriatric Depression Scale scores are shown. Error bars are SEM. Cohen’s d effect size (small 0.2, medium 0.4, large 1.0)
Fig. 2
Fig. 2
Anxiety scores are higher in PiB stage 2, specifically in APOEε4 carriers. Anxiety scores adjusted for age, sex, education, and Mini-Mental State Examination and Geriatric Depression Scale scores are shown. Error bars are SEM. Cohen’s d effect size (small 0.2, medium 0.4, large 1.0)
Fig. 3
Fig. 3
Among cognitively normal older adults with elevated neocortical PiB binding, anxiety scores increase as a function of subcortical PiB binding. Regression lines for anxiety and PiB binding in cortex and selected subcortical regions are shown. Anxiety scores are adjusted for age, sex, education, Mini-Mental State Examination and Geriatric Depression Scale scores. Partial Pearson’s correlations (R) between PiB binding and anxiety scores, adjusted for covariates are shown

References

    1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602. doi: 10.1001/archpsyc.62.6.593. - DOI - PubMed
    1. Braam AW, Copeland JR, Delespaul PA, Beekman AT, Como A, Dewey M, et al. Depression, subthreshold depression and comorbid anxiety symptoms in older Europeans: results from the EURODEP concerted action. J Affect Disord. 2014;155:266–72. doi: 10.1016/j.jad.2013.11.011. - DOI - PubMed
    1. Insel TR, Cuthbert BN. Medicine. Brain disorders? Precisely. Science. 2015;348:499–500. doi: 10.1126/science.aab2358. - DOI - PubMed
    1. Klunk WE. Amyloid imaging as a biomarker for cerebral beta-amyloidosis and risk prediction for Alzheimer dementia. Neurobiol Aging. 2011;32:S20–36. doi: 10.1016/j.neurobiolaging.2011.09.006. - DOI - PMC - PubMed
    1. Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, et al. Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study. Lancet Neurol. 2013;12:357–67. doi: 10.1016/S1474-4422(13)70044-9. - DOI - PubMed

Publication types

Substances